
Keywords: آنتیبادیهای مونوکلونال (mAbs); Monoclonal antibodies (mAbs); Therapeutic antibodies; Biologicals; Biosimilars; Biobetters; Antibody engineering; Antibody drug conjugates (ADC); Bispecific antibodies; Manufacture; Degradation; Stability; Formulation;